Solugen Raises $357M in Series D

Solugen has successfully raised $357M in a Series D at a $1.8B valuation led by Temasek, Baillie Gifford, BlackRock.

Company Overview

Solugen is a CleanTech company headquartered in Houston, TX, founded in 2016 with 300+ employees.

Bio-based chemicals using enzymatic technology for decarbonization

Fundraising Details

Amount Raised: $357M
Round Type: Series D
Valuation: $1.8B
Date: 2025-10-15
Investors: Temasek, Baillie Gifford, BlackRock

About Solugen

Bio-based chemicals using enzymatic technology for decarbonization The company is positioned in the CleanTech sector, serving a growing market with innovative solutions.

Key Information

Headquarters: Houston, TX
Founded: 2016
Team Size: 300+
Industry: CleanTech

What This Means

This funding round demonstrates strong investor confidence in Solugen's vision and execution. The capital will likely be used to:

Scale Operations: Expand the team and operational capacity
Product Development: Enhance existing products and develop new features
Market Expansion: Enter new markets and strengthen presence in existing ones
Technology Investment: Invest in infrastructure and technology capabilities

Industry Context

The CleanTech sector continues to attract significant investment as companies innovate to meet evolving market demands. Solugen's successful fundraising reflects the strong fundamentals and growth potential in this space.

Valuation Milestone

Reaching a $1.8B valuation marks an important milestone for Solugen, positioning the company among notable players in the CleanTech industry.

Looking Ahead

With this new capital, Solugen is well-positioned to execute on its growth strategy and continue building innovative solutions in the CleanTech space. The company's trajectory will be one to watch as it deploys this funding to achieve its next phase of growth.

This fundraising news was reported on 2025-10-15. For more information about Solugen, visit their headquarters at Houston, TX.

Solugen